Kynurenic acid and 3-hydroxykynurenine production from d-kynurenine in mice

Abstract

Kynurenic acid (KYNA), an antagonist of the α7 nicotinic acetylcholine receptor and the N-methyl-d-aspartate receptor, and 3-hydroxykynurenine (3-HK), a generator of reactive oxygen species, are neuroactive metabolites of the kynurenine pathway of tryptophan degradation. In the mammalian brain as elsewhere, both compounds derive from a common bioprecursor, l-kynurenine (l-KYN). Recent studies in rats demonstrated that d-kynurenine (d-KYN), a metabolite of the bacterial amino acid d-tryptophan, can also function as a bioprecursor of brain KYNA. We now investigated the conversion of systemically administered d-KYN to KYNA in mice and also explored the possible production of 3-HK in the same animals. Thirty min after an injection of d-KYN or l-KYN (30mg/kg, i.p.), newly produced KYNA and 3-HK were recovered from plasma, liver, forebrain and cerebellum in all cases. Using a new chiral separation method, 3-HK produced from d-KYN was positively identified as D-3-HK. l-KYN was the more effective precursor of KYNA in all tissues and also exceeded d-KYN as a precursor of brain 3-HK. In contrast, d-KYN was more potent as a precursor of 3-HK in the liver. The production of both KYNA and 3-HK from d-KYN was rapid in all tissues, peaking at 15–30min following a systemic injection of d-KYN. These results show that biosynthetic routes other than those classically ascribed to l-KYN can account for the synthesis of both KYNA and 3-HK in vivo. This new insight may be of significant physiological or pathological relevance.